U.S. Luxury Stock News

In March 2026, Illumina and Labcorp expanded their precision oncology collaboration to develop and distribute next-generation sequencing-based cancer tests, including co-commercializing Labcorp's FDA-authorized PGDx elio plasma focus Dx liquid biopsy alongside Illumina's FDA-approved TruSight Oncology Comprehensive for solid tumors. This alliance aims to widen access to both tissue and liquid biopsy biomarker testing, support companion diagnostic development for drugmakers, and strengthen...

Redemption and Buyback Moves Put Capital Management in Focus Banc of California (BANC) drew investor attention after announcing plans to redeem $385 million of subordinated notes originally issued by Pacific Western Bank and to extend its share repurchase plan through March 16, 2027. See our latest analysis for Banc of California. The latest debt redemption and buyback announcements arrive after a 1-day share price return of 3.53% to US$17.58. However, the 90-day share price return of 8.86%...

Wondering if Artisan Partners Asset Management at around US$36.39 is offering value right now, or if the easy money has already been made. The stock is up 1.6% over the last 7 days, although it shows a 9.7% decline over 30 days, a 12.1% decline year to date, and a 0.3% return over the past year, which may have shifted how investors see its risk and return profile. Recent coverage has focused on the stock’s mixed return picture, with a modest 0.3% 1 year return sitting alongside a 46.5%...

Comfort Systems USA, Inc. (NYSE: FIX) was added to the FTSE All-World Index (USD) on 21 March 2026, further cementing its position among globally tracked construction and building-services companies. This index inclusion coincides with growing attention on the company’s upcoming fiscal Q1 2026 earnings, where analysts are looking for double-digit earnings growth and continued backlog strength. We’ll now examine how the FTSE All-World Index inclusion could influence Comfort Systems USA’s...

This article walks through key numbers to help you judge whether Moody's current share price lines up with its underlying worth and if the stock looks expensive, cheap or somewhere in between. Moody's last closed at US$436.25, with returns of 1.8% over 7 days, an 8.7% decline over 30 days, a 12.6% decline year to date and a 6.2% decline over the last year. The 3 year and 5 year returns stand at 47.1% and 47.0% respectively. Recent coverage has focused on how Moody's performance over 3 and 5...

POET Technologies reported in the past that it had shifted from development to execution by securing more than US$225,000,000 in financing in 2025, adding a further US$150,000,000 in January 2026, and landing a production order above US$5,000,000 for its POET Infinity optical engines. This combination of large-scale funding and an initial multi-million-dollar production order highlights how POET is positioning its optical engine platform for commercial-scale manufacturing and customer...

Rezolve AI (RZLV) has just put fresh FY 2025 numbers on the table, with second half revenue of about US$40.5 million and a basic EPS loss of US$0.14, backed by trailing twelve month revenue of roughly US$46.8 million and a basic EPS loss of US$0.38. The company has seen revenue move from just US$0.1 million in the second half of FY 2024 to US$6.3 million in the first half of FY 2025 and then to US$40.5 million in the latest half, while basic EPS losses shifted from US$0.98 to US$0.25 and then...

If you are wondering whether Buckle at around US$50.36 offers solid value or is pricing in too much optimism, this breakdown will help you frame that question clearly. The stock has had a mixed short term patch, with a 0.6% return over the last week, a 6.0% decline over the past month, and a 6.5% decline year to date, as well as a 42.9% return over the last year and 84.3% and 112.4% returns over the past 3 and 5 years. Recent coverage has focused on Buckle in the context of broader retail...

Wondering if Cardinal Health at around US$211 a share still offers value, or if most of the opportunity is already reflected in the price. The stock has returned 2.0% over the last week, seen a 7.8% decline over the last 30 days, yet is up 2.7% year to date and 55.8% over the past year, with very large gains over 3 and 5 years. Recent headlines have focused on Cardinal Health's broader role as a major healthcare distributor and solutions provider, which keeps attention on how its scale and...

M/I Homes (MHO) has been drawing attention after recent share price swings, with the stock up about 3.2% on the day but showing a 13.9% decline over the past month. See our latest analysis for M/I Homes. That 3.2% 1 day share price gain comes after a 13.9% 30 day share price decline and a mildly negative year to date share price return. However, the 3 year total shareholder return near 100% and 5 year total shareholder return near 96% highlight how longer term holders have still seen strong...

Kodiak Sciences (KOD) is back in focus after reporting that its GLOW2 Phase 3 study of Zenkuda in diabetic retinopathy met key efficacy and safety endpoints, supporting a multi-indication, BLA-ready profile. See our latest analysis for Kodiak Sciences. The Zenkuda update arrives alongside sharp recent moves in the stock, with a 74.46% 7 day share price return and a 42.24% 30 day share price return. The 1 year total shareholder return is very large, suggesting momentum has picked up sharply...

Scorpio Tankers (STNG) has been actively reshaping its fleet by agreeing to sell multiple MR and LR2 product tankers, including two 2015 built scrubber fitted vessels, while also arranging newbuilding deliveries through 2029. See our latest analysis for Scorpio Tankers. The latest vessel sales and newbuilding commitments come as Scorpio Tankers’ share price sits at US$74.66, with a 90 day share price return of 46.88% and a 1 year total shareholder return of 102.23%. This points to strong...

First Keystone (FKYS) just wrapped up FY 2025 with fourth quarter revenue of US$7.8 million and a basic EPS loss of US$0.10, while the trailing twelve months show total revenue of US$40.3 million and EPS of US$0.99. Over recent periods the company has seen quarterly revenue move from US$10.4 million in Q4 2024 to US$11.5 million in Q2 2025 before landing at US$7.8 million in Q4 2025, with basic EPS shifting from US$0.37 in Q4 2024 to US$0.47 in Q2 2025 before slipping into a small loss in the...

Harrow recently completed a private fixed‑income offering of US$50.0 million in 8.625% senior unsecured notes due September 15, 2030, issued at 100.25% of par and guaranteed by certain subsidiaries. The new notes, fungible with Harrow’s existing US$250.0 million 2030 notes and sold to qualified institutional buyers under Rule 144A and Regulation S, further reshape the company’s capital structure to support general corporate and growth initiatives. Now we’ll examine how this additional...

CRH (NYSE:CRH) has drawn investor attention after recent share price volatility, with the stock closing at US$105.12 and showing mixed returns across the past week, month, past 3 months, and year to date. See our latest analysis for CRH. The recent 1 day share price return of 3.15% comes after a weaker stretch, with 30 day and year to date share price returns of 12.39% and 16.86% declines. At the same time, 1 year, 3 year, and 5 year total shareholder returns of 19.58%, 122.30%, and 160.89%...

Raymond James said that Independent Contractor Division director Kirk Bell has been appointed president of the division, effective April 1, 2026, joining both the firm’s Senior Leadership and Private Client Group Executive Leadership teams after prior president Shannon Reid’s resignation. This leadership change comes as the firm balances softer capital markets activity with growth in asset management and private client revenues ahead of its upcoming fiscal Q2 2026 earnings release. Next,...

Allison Transmission Holdings (NYSE:ALSN) is acquiring Dana’s Off-Highway business, expanding its reach beyond on-highway applications. The deal adds exposure to off-highway markets such as construction, agriculture and mining, widening Allison’s addressable customer base. Investors now have new information to assess Allison’s mix of end markets, revenue sources and integration priorities. Allison Transmission Holdings, trading at $117.06, has seen its share price rise 18.3% year to date...

Earlier this year, Workiva appointed Barbara Larson as executive vice president and chief financial officer, drawing on her prior finance leadership roles at Workday and VMware to help oversee its AI-enabled governance, risk, compliance and sustainability platform, which is guiding toward US$1.00 billion in revenue in 2026. Her emphasis on embedding AI more deeply into Workiva’s platform to respond to rising regulatory demands highlights how leadership decisions could shape the company’s...

Endava (NYSE:DAVA) has just turned in a mixed Q2 2026 scorecard, with revenue of £184.1 million, a basic EPS loss of £0.13 and net income loss of £6.9 million, set against a trailing twelve month picture that shows £743.9 million of revenue, a small EPS loss of £0.05 and a net income loss of £2.9 million. Over the past few quarters, revenue has moved from £195.6 million and EPS of £0.12 in Q2 2025 to £184.1 million and EPS of a £0.13 loss in Q2 2026, while quarterly net income shifted from a...

Global markets are wrestling with stubborn inflation risks, volatile energy prices, and shifting central bank expectations, which is pushing many investors to look more closely at real world infrastructure. The power grid sits at the heart of that topic, linking AI data centers, electrified transport, and everyday homes to reliable energy. Our Power Grid Technology Stocks screener filters for profitable companies that build and equip this backbone, focusing on those already earning money from...

On 31 March 2026, Scholar Rock announced it had resubmitted its Biologics License Application to the FDA for apitegromab in spinal muscular atrophy, now incorporating both the Catalent Indiana site and a second U.S.-based fill-finish facility in line with recent regulatory guidance. The resubmission, coming after an earlier Complete Response Letter that cited only third-party manufacturing observations, highlights how Scholar Rock has worked with Novo Nordisk’s Catalent unit and the FDA to...

In March 2026, Dr. Scholl’s Shoes announced a limited-edition collaboration with Kontoor Brands’ Wrangler, and J.Crew introduced an exclusive Lee x J.Crew capsule, both featuring Americana-inspired footwear, denim, and apparel across multiple categories and price points. These collaborations highlight how Kontoor is using heritage partnerships and fashion-forward capsules to broaden its reach, refresh brand perception, and tap into new style-minded consumer groups. Next, we’ll examine how...

If you are wondering whether Dynex Capital is priced attractively at around US$12.76, it helps to separate short term share price swings from what the underlying value might suggest. The stock has recently shown mixed returns, with a 2.4% gain over the last 7 days, a 9.1% decline over 30 days, and year to date and 1 year returns of 9.4% decline and 15.2% respectively, while the 3 year and 5 year returns sit at 60.2% and 23.8%. Recent coverage has focused on how income focused investors view...

NexPoint Diversified Real Estate Trust (NXDT) has wrapped up FY 2025 with fourth quarter total revenue of US$19.1 million, basic EPS of a US$0.75 loss, and funds from operations of US$86.1 million. This rounds out a trailing 12 month revenue line of US$86.0 million and a net loss of US$130.2 million. Over recent quarters, revenue has moved from US$28.7 million in Q1 2025 to US$21.2 million in Q2, US$16.9 million in Q3, and US$19.1 million in Q4. Quarterly basic EPS has ranged from a US$0.99...